sinc
develop
next
generationsequenc
ng
technolog
use
metagenom
approach
grown
consider
consid
effici
unbias
tool
clinic
virolog
particular
character
viral
acut
respiratori
infect
ari
sever
advantag
metagenom
ng
mng
compar
convent
realtim
polymeras
chain
reaction
pcr
assay
highlight
firstli
full
viral
genet
inform
immedi
avail
allow
investig
respiratori
outbreak
viral
epidemiolog
surveil
identif
specif
mutat
lead
antivir
resist
higher
virul
secondli
signific
improv
viral
ari
diagnosi
report
process
sequenc
independ
mng
abl
identifi
highli
diverg
viral
genom
rare
respiratori
pathogen
discov
respiratori
virus
miss
target
pcr
howev
divers
viral
nucleic
acid
type
impair
develop
uniqu
viral
metagenom
workflow
allow
comprehens
character
virus
present
clinic
sampl
publish
viral
metagenom
protocol
optim
detect
either
dna
virus
rna
virus
addit
despit
grow
number
studi
use
metagenom
process
clinic
virolog
evalu
workflow
systemat
includ
clinic
sampl
qualiti
control
qc
implement
metagenom
protocol
involv
larg
number
step
control
ensur
qualiti
gener
sequenc
furthermor
specimen
specimen
environment
reagent
contamin
also
major
concern
metagenom
set
must
accur
evalu
object
studi
implement
qc
singl
metagenom
protocol
evalu
detect
broad
panel
dna
rna
virus
clinic
respiratori
sampl
total
respiratori
sampl
collect
patient
hospit
univers
hospit
lyon
hospic
civil
de
lyon
hcl
retrospect
select
evalu
metagenom
approach
select
specimen
includ
variou
type
clinic
sampl
nasopharyng
swab
n
aspir
n
sputum
n
sampl
initi
sent
laboratori
routin
viral
diagnosi
ari
use
semiquantit
realtim
pcr
assay
target
comprehens
panel
dna
rna
virus
rgene
marci
l
franc
panel
includ
influenza
viru
type
b
adenoviru
cytomegaloviru
epsteinbarr
viru
human
herp
viru
human
bocaviru
hbov
human
rhinoviru
respiratori
syncyti
viru
human
parainfluenza
viru
human
coronaviru
hcov
human
metapneumoviru
measl
viru
twentytwo
sampl
posit
one
target
viru
character
multipl
viral
infect
neg
target
virus
sampl
also
found
neg
use
filmarray
respiratori
panel
fa
rp
pcr
test
rest
sampl
store
mng
analysi
sampl
viral
enrich
method
appli
thaw
vortex
sampl
lowspe
centrifug
g
min
follow
filtrat
supernat
use
filter
sartoriu
germani
remov
eukaryot
bacteri
cell
without
loss
larg
virus
turbo
dnase
treatment
min
life
technolog
carlsbad
ca
usa
total
nucleic
acid
extract
use
nuclisen
easymag
platform
marci
l
etoil
franc
follow
ethanol
precipit
h
previous
describ
modifi
whole
transcriptom
amplif
perform
amplifi
dna
rna
viral
nucleic
acid
sigmaaldrich
darmstadt
germani
amplifi
dna
cdna
purifi
use
qiaquick
column
qiagen
hilden
germani
quantifi
use
qubit
fluoromet
hs
dsdna
kit
life
technolog
carlsbad
ca
usa
nextera
xt
dna
librari
prepar
nextera
xt
index
kit
use
prepar
pairedend
librari
accord
manufactur
recommend
illumina
san
diego
ca
usa
normal
pool
librari
vv
made
quantifi
use
univers
kapa
librari
quantif
kit
kapa
biosystem
wilmington
usa
phix
genom
ad
quantifi
librari
sequenc
illumina
nextseq
platform
fig
addit
notic
wetlab
process
design
prevent
contamin
much
possibl
reagent
store
prepar
dnafre
room
patient
sampl
open
laminar
flow
hood
prepcr
room
amplif
step
tube
handl
store
postpcr
room
stepwis
bioinformat
filter
pipelin
use
qualiti
filter
read
use
cutadapt
sickl
remov
human
archaeal
bacteri
fungal
sequenc
align
read
bwa
mem
databas
use
refseq
archaea
refseq
bacteria
refseq
fungi
remain
read
align
ezvir
viral
databas
bacteriophag
genom
refseq
databas
download
februari
use
bwa
mem
normal
compar
viral
genom
coverag
valu
perform
use
read
per
kilobas
viru
refer
sequenc
per
million
map
read
rpkm
ratio
rpkm
ratio
correct
differ
sampl
sequenc
depth
viral
gene
length
viral
read
express
rpkm
notempl
control
ntc
subtract
viral
read
rpkm
sampl
within
batch
prior
analysi
sampl
consid
posit
particular
viru
rpkm
viru
posit
threshold
regard
genom
coverag
pattern
appli
requir
cover
particular
region
genom
latter
requir
could
import
correctli
identifi
rna
viru
subtyp
high
recombin
frequenc
within
speci
implement
specif
viral
famili
respiratori
specimen
spike
intern
qualiti
control
iqc
sampl
prepar
bacteriophag
commerci
kit
rna
intern
control
rgene
select
iqc
posit
extern
qualiti
control
eqc
use
viral
transport
medium
spike
concentr
use
iqc
notempl
control
ntc
implement
evalu
contamin
process
ntc
constitut
viral
transport
medium
sigmavirocult
mwe
corsham
uk
process
mng
step
two
qc
test
qct
perform
semiquantit
detect
use
commerci
realtim
pcr
assay
rna
intern
control
rgene
amplif
step
fig
valid
criteria
semiquantit
pcr
cycl
threshold
ct
ct
iqc
eqc
detect
ntc
evalu
sequenc
perform
quantifi
number
read
align
genom
rpkm
genom
coverag
genom
access
number
fig
valid
criteria
genom
coverag
posit
eqc
rpkm
iqc
statist
analys
perform
use
graphprism
version
appli
appropri
statist
test
associ
mng
viral
realtim
pcr
assay
determin
appli
pearson
correl
coeffici
differ
median
distribut
evalu
u
test
pvalu
less
consid
statist
signific
bacteriophag
singlestrand
rna
viru
ssrna
use
iqc
valid
whole
metagenom
process
sampl
order
optim
iqc
spike
level
sensit
metagenom
analysi
workflow
detect
first
evalu
tenfold
serial
dilut
nasopharyng
swab
test
neg
use
fa
rp
detect
intern
level
spike
ct
rang
dilut
ct
dilut
full
partial
genom
coverag
obtain
spike
level
intern
coverag
rang
dilut
dilut
highest
spike
level
total
number
viral
read
map
lowest
spike
level
fig
limit
number
ng
read
consum
iqc
detect
optim
spike
condit
determin
dilut
use
rest
studi
total
clinic
respiratori
sampl
patient
ari
caus
broad
panel
dna
rna
virus
unknown
etiolog
analyz
singl
mng
workflow
librari
sequenc
mean
million
read
pass
qualiti
filter
rang
read
human
sequenc
repres
main
part
ng
read
posit
sampl
mean
neg
sampl
mean
ntc
mainli
compos
bacteri
read
proport
viral
read
rang
mean
posit
sampl
neg
sampl
addit
file
viral
metagenom
result
valid
accord
criteria
describ
method
section
molecular
detect
perform
librari
prepar
neg
ntc
sequenc
viral
contamin
repres
total
read
gener
ntc
includ
read
rpkm
target
virus
read
rpkm
read
rpkm
map
influenza
hbov
detect
respect
posit
eqc
success
detect
pcr
posit
ct
sequenc
step
genom
coverag
rpkm
regard
iqc
result
sampl
pass
pcr
ct
valu
therefor
process
total
sampl
pass
rpkm
fig
sampl
genom
coverag
rang
addit
file
sampl
pass
includ
one
sputum
previous
test
neg
use
realtim
pcr
sampl
one
hcov
posit
sputum
sampl
ct
one
hbov
posit
nasopharyng
swab
sampl
ct
one
nasopharyng
aspir
test
posit
hbov
cmv
sampl
ct
respect
sampl
sampl
none
realtim
pcr
target
virus
detect
bioinformat
analysi
sampl
sequenc
replic
similarli
fail
iqc
hbov
detect
could
test
replic
sampl
owe
insuffici
quantiti
viral
metagenom
result
sampl
valid
viral
read
repres
total
read
gener
fig
sampl
number
read
map
hcov
hcov
genom
coverag
result
therefor
valid
sampl
overal
mng
result
valid
sampl
includ
posit
sampl
neg
sampl
evalu
metagenom
workflow
perform
use
previous
valid
respiratori
sampl
test
posit
viral
realtim
pcr
target
repres
panel
dna
rna
virus
sampl
test
viral
metagenom
sequenc
allow
identif
viral
genotyp
match
target
pcr
result
ontarget
viral
genom
coverag
rang
median
target
virus
realtim
pcr
ct
valu
rang
ct
median
ct
six
multipl
viral
infect
involv
differ
virus
also
fulli
character
tabl
sampl
sampl
test
posit
dna
virus
rna
virus
use
realtim
pcr
mng
result
crosscheck
duplic
report
rpkm
deviat
lower
log
target
viru
mng
result
replic
summar
addit
file
regard
mng
result
obtain
neg
sampl
valid
iqc
clinic
relev
viru
detect
strong
correl
mng
realtim
pcr
result
obtain
viral
genom
type
rang
linear
ssrna
virus
linear
ssdna
virus
fig
normal
read
count
significantli
lower
linear
dsdna
virus
viral
genom
type
fig
last
year
grow
number
viral
metagenom
protocol
publish
systemat
evalu
clinic
respiratori
sampl
valid
qc
still
lack
present
studi
describ
process
allow
sensit
detect
dna
rna
virus
singl
assay
implement
sever
qc
valid
whole
metagenom
workflow
first
iqc
implement
control
integr
reagent
equip
presenc
inhibitor
allow
valid
mng
result
sampl
bacteriophag
select
iqc
three
main
reason
firstli
wide
use
iqc
viral
realtim
pcr
assay
control
extract
inhibit
secondli
rna
viru
requir
control
random
revers
transcript
second
strand
synthesi
step
thirdli
ssrna
viru
small
genom
perfectli
character
therefor
easili
detect
bioinformat
analysi
without
need
extens
ng
read
use
iqc
previous
report
metagenom
analysi
cerebrospin
fluid
specimen
anoth
metagenom
studi
rna
includ
extract
iqc
use
purifi
rna
valid
viral
enrich
step
protocol
describ
herein
whole
virion
ad
clinic
sampl
begin
workflow
implement
control
first
step
process
avoid
unnecessari
librari
prepar
step
fail
end
workflow
abl
invalid
sampl
neither
virus
caus
ari
significantli
detect
metagenom
analysi
routin
pcr
screen
detect
hbov
hcov
retest
sampl
found
find
suggest
inhibit
competit
issu
process
without
use
iqc
sampl
would
mistakenli
classifi
fals
neg
mng
howev
expect
competit
virus
process
could
lead
nondetect
iqc
read
case
high
viral
load
thu
interpret
iqc
result
consid
proport
viral
read
sampl
although
observ
iqc
read
may
also
reduc
sampl
greater
number
patient
cell
may
affect
sensit
assay
addit
iqc
implement
neg
extern
control
contamin
issu
frequent
report
metagenom
studi
may
lead
misinterpret
clinic
practic
mng
read
neg
control
mainli
compos
bacteri
read
howev
viral
read
mainli
deriv
prokaryot
virus
also
detect
could
present
reagent
kitom
may
repres
laboratori
contamin
bleedov
contamin
highli
posit
sampl
within
batch
contamin
observ
present
studi
highli
posit
hbov
sampl
sampl
ct
contamin
ntc
hbov
read
rpkm
rpkm
clinic
set
subtract
ntc
viral
read
prior
interpret
sampl
result
therefor
requir
evalu
workflow
clinic
respiratori
sampl
test
repres
panel
dna
rna
virus
use
realtim
pcr
select
workflow
base
previou
public
singl
protocol
specif
develop
stool
specimen
evalu
mock
commun
contain
high
concentr
spike
virus
interestingli
multipl
viral
infect
involv
dna
rna
virus
fulli
character
highlight
power
mng
approach
univers
method
viru
character
despit
lack
common
viral
sequenc
addit
virus
target
pcr
viral
read
deriv
commens
virom
includ
virus
anellovirida
famili
gener
pcr
neg
posit
sampl
ntc
regard
sensit
mng
approach
wide
rang
semiquantit
realtim
pcr
ct
valu
cover
thorburn
et
al
compar
mng
convent
realtim
pcr
detect
rna
virus
nasopharyng
swab
report
detect
cutoff
ct
mng
approach
workflow
allow
character
dna
rna
virus
semiquantit
realtim
pcr
ct
valu
consid
low
viral
load
major
critic
point
viral
metagenom
reduc
host
bacteri
compon
comparison
similar
studi
viral
read
herein
highli
repres
mean
exampl
studi
nasopharyng
aspir
test
posit
viral
pcr
assay
found
mean
viral
read
addit
strong
correl
result
mng
convent
realtim
pcr
obtain
regroup
virus
accord
genom
type
similar
find
report
elsewher
suggest
mng
result
could
use
semiquantit
measur
viral
load
clinic
sampl
lower
rpkm
valu
dsdna
virus
compar
viral
genom
type
notic
previous
describ
ebv
cmv
necessari
use
dnase
reduc
host
contamin
may
affect
fragil
larg
dsdna
virus
detect
limit
mng
analysi
mainli
depend
viral
load
total
number
read
per
sampl
effect
could
overcom
increas
sequenc
depth
howev
chose
limit
cost
workflow
reagent
cost
mng
approach
rel
low
estim
thank
viral
enrich
process
amplif
method
use
commerci
kit
dilut
use
univers
workflow
dna
rna
virus
also
reduc
reagent
cost
compar
metagenom
protocol
target
dna
rna
virus
separ
contrast
target
ng
specif
virus
follow
specif
amplif
pcr
time
cheaper
base
experi
eg
influenza
viru
sequenc
due
sever
limit
includ
cost
long
turnaround
time
viral
metagenom
current
consid
secondlin
approach
use
primari
routin
diagnost
tool
howev
improv
sequenc
technolog
allow
realtim
sequenc
minion
sequenc
oxford
nanopor
oxford
unit
kingdom
could
envis
mng
gradual
use
primari
diagnosi
midterm
case
high
viral
load
suffici
dna
input
amplif
workflow
might
use
minion
sequenc
approach
describ
preliminari
work
crucial
bring
standard
routin
clinic
use
mng
process
within
reason
timefram
evalu
studi
greater
number
sampl
urgent
need
establish
iqc
cutoff
accord
number
viral
human
bacteri
read
defin
perform
workflow
includ
repeat
reproduc
well
detect
limit
viru
addit
improv
bioinformat
pipelin
explor
includ
implement
threshold
regard
genom
coverag
pattern
impact
perform
workflow
establish
potenti
mng
promis
sever
factor
inhibit
competit
contamin
lead
dramat
misinterpret
clinic
set
herein
provid
effici
easi
use
mng
workflow
includ
qualiti
control
success
evalu
comprehens
character
broad
repres
panel
dna
rna
virus
variou
type
clinic
respiratori
sampl
